TP53 and cancer: Furthermore, germline TP53 mutations cause the Li–Fraumeni syndrome (LFS) of cancer predisposition [4], and the stratification of LFS patients according to TP53 mutations indicated that, compared with nonsense mutations, missense p53 mutations may correlate with accelerated tumor onset or distinct cancer spectra [5].